Company profile for Mydecine

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Mydecine™ is a vertically integrated company engaged to utilize the vast medicinal, health and wellness capabilities of the many compounds found in mycology as a whole. The Company, through its three divisions, “Mydecine Farms”, “Mydecine Wellness”, and “Psydecine Labs” aims to be an industry pioneer in the cultivation, processing, product development, and research and development of the many beneficial and exc...
Mydecine™ is a vertically integrated company engaged to utilize the vast medicinal, health and wellness capabilities of the many compounds found in mycology as a whole. The Company, through its three divisions, “Mydecine Farms”, “Mydecine Wellness”, and “Psydecine Labs” aims to be an industry pioneer in the cultivation, processing, product development, and research and development of the many beneficial and exciting compounds that are found in various strains of mushroom and fungi from all around the world.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
789 West Pender Street Suite 810 Vancouver, BC V6C 1H2 Canada
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com//news-release/2024/02/07/2825615/0/en/Mydecine-Innovations-Group-Receives-Two-Notice-of-Allowances-from-USPTO-for-its-MYCO-005-and-MYCO-006-Family-of-Compounds.html

GLOBENEWSWIRE
07 Feb 2024

https://www.globenewswire.com//news-release/2023/11/28/2787361/0/en/Mydecine-Announces-Update-Regarding-the-Special-Access-Program.html

GLOBENEWSWIRE
28 Nov 2023

https://www.globenewswire.com//news-release/2023/10/31/2769817/0/en/Mydecine-Innovations-Group-Files-Prospectus-Supplement-Announces-Closing-Under-Share-Subscription-Agreements.html

GLOBENEWSWIRE
31 Oct 2023
Mydecine Provides Q4 2023 Business Update
Mydecine Provides Q4 2023 Business Update

26 Oct 2023

// GLOBENEWSWIRE

https://www.globenewswire.com//news-release/2023/10/26/2767127/0/en/Mydecine-Provides-Q4-2023-Business-Update.html

GLOBENEWSWIRE
26 Oct 2023

https://www.globenewswire.com//news-release/2023/10/12/2758940/0/en/Mydecine-Innovations-Group-Announces-Admission-to-Trading-on-the-AQSE-Growth-Market-in-London-UK.html

GLOBENEWSWIRE
12 Oct 2023

https://www.globenewswire.com//news-release/2023/10/10/2757124/0/en/Mydecine-Innovations-Group-Announces-Admission-to-Trading-on-the-AQSE-Growth-Market-in-London-UK-and-First-Day-of-Dealings.html

GLOBENEWSWIRE
10 Oct 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty